These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8555955)

  • 41. HIV risk-taking behaviour among amphetamine users in Sydney, Australia.
    Hando J; Hall W
    Addiction; 1994 Jan; 89(1):79-85. PubMed ID: 8148747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of supervised injection facilities and injection risk behaviours among young drug injectors.
    Bravo MJ; Royuela L; De la Fuente L; Brugal MT; Barrio G; Domingo-Salvany A;
    Addiction; 2009 Apr; 104(4):614-9. PubMed ID: 19215603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methadone maintenance and the likelihood of risky needle-sharing.
    Caplehorn JR; Ross MW
    Int J Addict; 1995 May; 30(6):685-98. PubMed ID: 7657397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
    Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
    J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The preparedness to share injecting equipment: an analysis using vignettes.
    McKeganey N; Abel M; Taylor A; Frischer M; Goldberg D; Green S
    Addiction; 1995 Sep; 90(9):1253-60. PubMed ID: 7580822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knowledge, attitudes and beliefs of European injecting drug users concerning preventive measures for HIV.
    Richardson SC; Papaevangelou G; Ancelle-Park R
    Eur J Epidemiol; 1994 Apr; 10(2):135-42. PubMed ID: 7813690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anabolic steroid users identified by needle and syringe exchange contact.
    Morrison CL
    Drug Alcohol Depend; 1994 Oct; 36(2):153-5. PubMed ID: 7851283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prison experience of injecting drug users in Glasgow.
    Covell RG; Frischer M; Taylor A; Goldberg D; Green S; McKeganey N; Bloor M
    Drug Alcohol Depend; 1993 Mar; 32(1):9-14. PubMed ID: 8486087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
    Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Needle sharing in The Netherlands: an ethnographic analysis.
    Grund JP; Kaplan CD; Adriaans NF
    Am J Public Health; 1991 Dec; 81(12):1602-7. PubMed ID: 1746657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada.
    Shaw SY; Shah L; Jolly AM; Wylie JL
    Addiction; 2007 Oct; 102(10):1626-35. PubMed ID: 17854339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determinants of HIV infection and recent risk behaviour among injecting drug users in Berlin by site of recruitment.
    Stark K; Müller R; Wirth D; Bienzle U; Pauli G; Guggenmoos-Holzmann I
    Addiction; 1995 Oct; 90(10):1367-75. PubMed ID: 8616465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Continuing drug risk behaviour: shared use of injecting paraphernalia among London heroin injectors.
    Gossop M; Griffiths P; Powis B; Williamson S; Fountain J; Strang J
    AIDS Care; 1997 Dec; 9(6):651-60. PubMed ID: 26672149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study.
    Huo D; Ouellet LJ
    J Acquir Immune Defic Syndr; 2007 May; 45(1):108-14. PubMed ID: 17460474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The sharing of injecting equipment among drug users attending prescribing clinics and those using needle-exchanges.
    Klee H; Faugier J; Hayes C; Morris J
    Br J Addict; 1991 Feb; 86(2):217-23. PubMed ID: 2021704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users.
    Murray JM; Law MG; Gao Z; Kaldor JM
    Int J Epidemiol; 2003 Oct; 32(5):708-14. PubMed ID: 14559736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measuring the impact of needle exchange programs among injecting drug users through the National Behavioural Surveillance in Bangladesh.
    Jenkins C; Rahman H; Saidel T; Jana S; Hussain AM
    AIDS Educ Prev; 2001 Oct; 13(5):452-61. PubMed ID: 11718444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.